Bruce N. Jacobs

Insider Reports History

Entity
Individual
Location
C/O Kymera Therapeutics, Inc., 200 Arsenal Yards, Suite 230, Watertown, MA
Signature
/s/ Bruce N. Jacobs
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bruce N. Jacobs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kymera Therapeutics, Inc. Chief Financial Officer Common Stock 169K $5.9M $34.98 Jun 27, 2024 Direct
Kymera Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 105K Jun 27, 2024 Direct

Insider Reports Filed by Bruce N. Jacobs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KYMR Kymera Therapeutics, Inc. Jun 27, 2024 2 $52K 4 Jun 28, 2024 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2024 5 -$165K 4 Mar 4, 2024 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Jun 2, 2023 2 $20.8K 4 Jun 2, 2023 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2023 4 -$42.5K 4 Mar 3, 2023 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Oct 21, 2022 2 $20.8K 4 Oct 24, 2022 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Oct 17, 2022 2 $20.8K 4 Oct 17, 2022 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. May 3, 2022 2 $41.6K 4 May 3, 2022 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Jan 14, 2022 2 $20.8K 4 Jan 14, 2022 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Jan 12, 2022 5 -$746K 4 Jan 14, 2022 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Dec 3, 2021 5 -$515K 4 Dec 3, 2021 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Nov 23, 2021 2 $20.8K 4 Nov 23, 2021 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Sep 3, 2021 4 -$622K 4 Sep 3, 2021 Chief Financial Officer
KYMR Kymera Therapeutics, Inc. Jun 3, 2021 4 -$448K 4 Jun 4, 2021 Chief Financial Officer